* Ocugen Inc is expected to show no change in quarterly revenue when it reports results on May 3 (estimated) for the period ending March 31 2024
*
* LSEG's mean analyst estimate for Ocugen Inc is for a loss of 6 cents per share.
* The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 3 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in the last three months.
* Wall Street's median 12-month price target for Ocugen Inc is $5.00, above its last closing price of $1.32.
Previous quarterly performance (using preferred earnings measure in US dollars).
QUARTER STARMINESM LSEG IBES ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT ESTIMATE MET, SE %
E® MISSED
Dec. 31 2023 -0.06 -0.03 Beat 53.8
Sep. 30 2023 -0.07 -0.07 -0.06 Beat 14.3
Jan. 1 0001 -0.07 -0.07 -0.08 Missed -9.1
Mar. 31 2023 -0.11 -0.11 -0.07 Beat 35.2
Dec. -0.10 -0.10 -0.10 Met -2
31 2022
Sep. 30 2022 -0.10 -0.10 -0.10 Met -1.7
Jun. 30 2022 -0.08 -0.08 -0.09 Missed -18.4
Mar. 31 2022 -0.07 0.00 -0.09 Missed -3,500
This summary was machine generated May 1 at 13:27 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
Comments